Cadherin-5 Facilitated the Differentiation of Human Induced Pluripotent Stem Cells into Sinoatrial Node-Like Pacemaker Cells by Regulating Β-Catenin

Wei Zhang,Fengyuan Wang,Lin Yin,Yanhong Tang,Xi Wang,Congxin Huang
DOI: https://doi.org/10.1002/jcp.31161
2024-01-01
Journal of Cellular Physiology
Abstract:Our study was conducted to investigate whether cadherin-5 (CDH5), a vascular endothelial cell adhesion glycoprotein, could facilitate the differentiation of human induced pluripotent stem cells (hiPSCs) into sinoatrial node-like pacemaker cells (SANLPCs), following previous findings of silk-fibroin hydrogel-induced direct conversion of quiescent cardiomyocytes into pacemaker cells in rats through the activation of CDH5. In this study, the differentiating hiPSCs were treated with CDH5 (40 ng/mL) between Day 5 and 7 during cardiomyocytes differentiation. The findings in the present study demonstrated that CDH5 stimulated the expression of pacemaker-specific markers while suppressing markers associated with working cardiomyocytes, resulting in an increased proportion of SANLPCs among hiPSCs-derived cardiomyocytes (hiPSC-CMs) population. Moreover, CDH5 induced typical electrophysiological characteristics resembling cardiac pacemaker cells in hiPSC-CMs. Further mechanistic investigations revealed that the enriched differentiation of hiPSCs into SANLPCs induced by CDH5 was partially reversed by iCRT14, an inhibitor of beta-catenin. Therefore, based on the aforementioned findings, it could be inferred that the regulation of beta-catenin by CDH5 played a crucial role in promoting the enriched differentiation of hiPSCs into SANLPCs, which presents a novel avenue for the construction of biological pacemakers in forthcoming research.
What problem does this paper attempt to address?